Tumor stroma as contributing factor in the lymph node metastases process?

por Mesker, Wilma E., van Pelt, Gabi W., Tollenaar, Rob A.E.M.
Publicado 2019

Detection of Tumor Cells in Bone Marrow, Peripheral Blood and Lymph Nodes by Automated Imaging Devices

por Mesker, Wilma E., Vrolijk, Hans, Sloos, Willem C. R., Tollenaar, Rob A. E. M., Tanke, Hans J.
Publicado 2006

Biomarker discovery in MALDI-TOF serum protein profiles using discrete wavelet transformation

por Alexandrov, Theodore, Decker, Jens, Mertens, Bart, Deelder, Andre M., Tollenaar, Rob A. E. M., Maass, Peter, Thiele, Herbert
Publicado 2009

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content

por Sandberg, Tessa P., Oosting, Jan, van Pelt, Gabi W., Mesker, Wilma E., Tollenaar, Rob A. E. M., Morreau, Hans
Publicado 2018

Erratum: Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content

por Sandberg, Tessa P., Oosting, Jan, van Pelt, Gabi W., Mesker, Wilma E., Tollenaar, Rob A.E.M., Morreau, Hans
Publicado 2019

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

por Zunder, Stéphanie M., van Pelt, Gabi W., Gelderblom, Hans J., Mancao, Christoph, Putter, Hein, Tollenaar, Rob A., Mesker, Wilma E.
Publicado 2018

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis

por van den Broek, Alexandra J., Schmidt, Marjanka K., van ‘t Veer, Laura J., Tollenaar, Rob A. E. M., van Leeuwen, Flora E.
Publicado 2015

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer

por Ravensbergen, Cor J., Polack, Meaghan, Roelands, Jessica, Crobach, Stijn, Putter, Hein, Gelderblom, Hans, Tollenaar, Rob A. E. M., Mesker, Wilma E.
Publicado 2021

Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures

por Velstra, Berit, van der Burgt, Yuri E. M., Mertens, Bart J., Mesker, Wilma E., Deelder, André M., Tollenaar, Rob A. E. M.
Publicado 2012

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

por Mesker, Wilma E., Junggeburt, Jan M. C., Szuhai, Karoly, de Heer, Pieter, Morreau, Hans, Tanke, Hans J., Tollenaar, Rob A. E. M.
Publicado 2007

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

por Sandberg, Tessa P., Stuart, Maaike P. M. E., Oosting, Jan, Tollenaar, Rob A. E. M., Sier, Cornelis F. M., Mesker, Wilma E.
Publicado 2019

Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT

por Polack, Meaghan, Hagenaars, Sophie C., Couwenberg, Alice, Kool, Walter, Tollenaar, Rob A. E. M., Vogel, Wouter V., Snaebjornsson, Petur, Mesker, Wilma E.
Publicado 2022

The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer

por Ravensbergen, Cor J., Kuruc, Matthew, Polack, Meaghan, Crobach, Stijn, Putter, Hein, Gelderblom, Hans, Roy, Devjit, Tollenaar, Rob A. E. M., Mesker, Wilma E.
Publicado 2021

Identification of Human Serum Peptides in Fourier Transform Ion Cyclotron Resonance Precision Profiles

por Nicolardi, Simone, Dalebout, Hans, Bladergroen, Marco R., Mesker, Wilma E., Tollenaar, Rob A. E. M., Deelder, André M., van der Burgt, Yuri E. M.
Publicado 2012

The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma

por Krijgsman, Daniëlle, De Vries, Natasja L., Andersen, Morten N., Skovbo, Anni, Tollenaar, Rob A. E. M., Bastiaannet, Esther, Kuppen, Peter J. K., Hokland, Marianne
Publicado 2020

High-Volume versus Low-Volume for Esophageal Resections for Cancer: The Essential Role of Case-Mix Adjustments based on Clinical Data

por Wouters, Michael W., Wijnhoven, Bas P., Karim-Kos, Henrieke E., Blaauwgeers, Harriet G., Stassen, Laurents P., Steup, Willem-Hans, Tilanus, Huug W., Tollenaar, Rob A.
Publicado 2007

Meaning Making in Cancer Survivors: A Focus Group Study

por van der Spek, Nadia, Vos, Joel, van Uden-Kraan, Cornelia F., Breitbart, William, Tollenaar, Rob A. E. M., Cuijpers, Pim, Verdonck-de Leeuw, Irma M.
Publicado 2013

Serum N-glycome alterations in colorectal cancer associate with survival

por de Vroome, Stefan W., Holst, Stephanie, Girondo, Mar Rodriguez, van der Burgt, Yuri E.M., Mesker, Wilma E., Tollenaar, Rob A.E.M., Wuhrer, Manfred
Publicado 2018

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood

por Krijgsman, Daniëlle, De Vries, Natasja L., Andersen, Morten N., Skovbo, Anni, Tollenaar, Rob A.E.M., Møller, Holger J., Hokland, Marianne, Kuppen, Peter J.K.
Publicado 2020

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study

por Smit, Marloes A., van Pelt, Gabi W., Terpstra, Valeska, Putter, Hein, Tollenaar, Rob A. E. M., Mesker, Wilma E., van Krieken, J. Han J. M.
Publicado 2021